P

Plus Therapeutics
D

PSTV

1.21000
USD
0.02
(1.68%)
Market Closed
Volume
5,862
EPS
-2
Div Yield
-
P/E
-1
Market Cap
7,134,563
OverviewSignalsIdeasNews
Related Instruments
    A
    AMC
    -0.09500
    (-2.08%)
    4.48000 USD
    CMCSA
    CMCSA
    -0.590
    (-1.36%)
    43.46 USD
    C
    CNK
    -0.150
    (-0.47%)
    31.840 USD
    DIS
    DIS
    5.915
    (5.42%)
    115.67 USD
    F
    FOXA
    -1.825
    (-3.84%)
    45.640 USD
    I
    IMAX
    -0.340
    (-1.38%)
    24.220 USD
    NFLX
    NFLX
    -13.37
    (-1.60%)
    897.775 USD
    T
    T
    0.450
    (2.02%)
    23.17 USD
    More
News

Title: Plus Therapeutics

Sector: Healthcare
Industry: Biotechnology
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).